PRTAProthena Corporation plc

$512M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$60M+30705.6% YoY

Gross Profit

$39M64.9% margin

Operating Income

$28M46.5% margin

Net Income

$28M46.0% margin

EPS (Diluted)

$0.58

QoQ Revenue Growth

+37444.4%

Cash Flow

Operating Cash Flow

$37M

Free Cash Flow

$37M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$436M

Total Liabilities

$148M

Stockholders' Equity

$288M

Cash & Equivalents

$400M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60M	$195,000	+30705.6%
Gross Profit	$39M	-$17M	+328.3%
Operating Income	$28M	-$27M	+204.6%
Net Income	$28M	-$26M	+205.2%

Revenue Segments

Collaboration

$60M100%

PRTA Q2 2021 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena